CA3208742A1 - Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis - Google Patents
Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis Download PDFInfo
- Publication number
- CA3208742A1 CA3208742A1 CA3208742A CA3208742A CA3208742A1 CA 3208742 A1 CA3208742 A1 CA 3208742A1 CA 3208742 A CA3208742 A CA 3208742A CA 3208742 A CA3208742 A CA 3208742A CA 3208742 A1 CA3208742 A1 CA 3208742A1
- Authority
- CA
- Canada
- Prior art keywords
- weeks
- subject
- tapinarof
- study drug
- week
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150204P | 2021-02-17 | 2021-02-17 | |
| US63/150,204 | 2021-02-17 | ||
| US202163260322P | 2021-08-17 | 2021-08-17 | |
| US63/260,322 | 2021-08-17 | ||
| US202163261523P | 2021-09-23 | 2021-09-23 | |
| US63/261,523 | 2021-09-23 | ||
| US202263266535P | 2022-01-07 | 2022-01-07 | |
| US63/266,535 | 2022-01-07 | ||
| PCT/US2022/016819 WO2022178144A1 (en) | 2021-02-17 | 2022-02-17 | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3208742A1 true CA3208742A1 (en) | 2022-08-25 |
Family
ID=82900200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3208742A Pending CA3208742A1 (en) | 2021-02-17 | 2022-02-17 | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20240315985A1 (https=) |
| EP (1) | EP4294518A4 (https=) |
| JP (1) | JP2024506953A (https=) |
| AU (1) | AU2022223701A1 (https=) |
| CA (1) | CA3208742A1 (https=) |
| WO (1) | WO2022178144A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11497718B2 (en) | 2018-11-13 | 2022-11-15 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of atopic dermatitis |
| JP2025532421A (ja) * | 2022-10-10 | 2025-09-29 | 上海澤徳曼医薬科技有限公司 | 潰瘍を予防及び又は治療するためのスチルベン誘導体の使用 |
| WO2024125500A1 (zh) * | 2022-12-14 | 2024-06-20 | 上海泽德曼医药科技有限公司 | 一种局部药物组合物及其在医药上的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3297605T (pt) * | 2015-05-21 | 2022-05-30 | Dermavant Sciences GmbH | Composições farmacêuticas tópicas |
| US11497718B2 (en) * | 2018-11-13 | 2022-11-15 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of atopic dermatitis |
| US20200147000A1 (en) * | 2018-11-13 | 2020-05-14 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of chronic plaque psoriasis |
-
2022
- 2022-02-17 US US18/546,880 patent/US20240315985A1/en active Pending
- 2022-02-17 JP JP2023549892A patent/JP2024506953A/ja active Pending
- 2022-02-17 AU AU2022223701A patent/AU2022223701A1/en active Pending
- 2022-02-17 EP EP22756938.1A patent/EP4294518A4/en active Pending
- 2022-02-17 CA CA3208742A patent/CA3208742A1/en active Pending
- 2022-02-17 WO PCT/US2022/016819 patent/WO2022178144A1/en not_active Ceased
- 2022-02-17 US US17/674,577 patent/US20220265572A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP4294518A1 (en) | 2023-12-27 |
| WO2022178144A1 (en) | 2022-08-25 |
| EP4294518A4 (en) | 2025-01-08 |
| JP2024506953A (ja) | 2024-02-15 |
| US20240315985A1 (en) | 2024-09-26 |
| US20220265572A1 (en) | 2022-08-25 |
| AU2022223701A1 (en) | 2023-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mirmirani et al. | Short course of oral cyclosporine in lichen planopilaris | |
| CN101198362B (zh) | 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法 | |
| US20230106782A1 (en) | Use of tapinarof for the treatment of chronic plaque psoriasis | |
| US11938099B2 (en) | Use of tapinarof for the treatment of atopic dermatitis | |
| JP7532511B2 (ja) | Ｊａｋ阻害剤による尋常性白斑の局所治療 | |
| US20220265572A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| JP2024506953A5 (https=) | ||
| US20220395472A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| US20210030672A1 (en) | Topical treatment of vitiligo by a jak inhibitor | |
| US20210212962A1 (en) | Methods and compositions for the treatment of granuloma annulare or subcutaneous inflammation and non-infection granulomatous diseases | |
| US20230293431A1 (en) | Topical treatment of vitiligo by a jak inhibitor | |
| JPH0971539A (ja) | 外用鎮痒剤 | |
| KR20260027115A (ko) | 타피나로프를 사용하여 아토피 피부염을 치료하는 방법 | |
| EP4486305A1 (en) | Composition for treating atopic dermatitis | |
| EA052074B1 (ru) | Топическое лечение витилиго ингибитором jak |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250128 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250128 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250128 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260123 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260123 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260211 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260212 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260227 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260227 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260302 |